The patient's perspective of the adverse effects of glucocorticoid use: A systematic review of quantitative and qualitative studies. From an OMERACT working group
- 1 October 2020
- journal article
- review article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 50 (5) , 996-1005
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)Annals of the Rheumatic Diseases, 2013
- Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient surveyBMC Endocrine Disorders, 2012
- Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesAnnals of the Rheumatic Diseases, 2010
- Impact of corticosteroid-related symptoms in patients with immune thrombocytopenic purpura: Results of a survey of 985 patientsClinical Therapeutics, 2008
- Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspectiveHealth and Quality of Life Outcomes, 2008
- Corticosteroid-induced clinical adverse events: frequency, risk factors and patient?s opinionBritish Journal of Dermatology, 2007
- Medication beliefs among patients with inflammatory bowel disease who report low quality of life: a qualitative studyBMC Gastroenterology, 2007
- Difficult asthma: people's perspectives on taking corticosteroid therapyJournal of Clinical Nursing, 2007
- Treatment of chronic immune thrombocytopenic purpura: the patients’ perspectiveEuropean Journal of Haematology, 2007
- Using qualitative metasummary to synthesize qualitative and quantitative descriptive findingsResearch in Nursing & Health, 2007